Paris, August 24, 2023 – 6 p.m. CEST
CARMAT (FR0010907956, ALCAR, PEA-PME eligible), designer and developer of the most advanced total artificial heart in the world, aimed at offering a therapeutic alternative to patients suffering from advanced biventricular heart failure, informs its shareholders that due to practical considerations , the publication of the half-year results, initially scheduled for September 13, 2023, will take place on September 25, 2023 after market close.
The Company will hold a videoconference in French and English on the same day. The schedules and connection methods will be communicated to shareholders and the financial community shortly.
To receive all of CARMAT’s financial information in real time, send a request by email to [email protected]. Your registration will be immediate.